Cannabis
Cannabis Growth Opportunity Corporation Announces NAV of $2.51
Cannabis Growth Opportunity Corporation (“CGOC“, or the “Company“) (CSE: CGOC), a cannabis-focused investment corporation with both public and private cannabis holdings, announces the company’s updated net asset value per common share (“NAV“) of $2.51 at the close of business on November 15, 2019. This represents growth of 8% since the Initial Public Offering (“IPO“), on January 26, 2018, and a decrease of 9% year to date.
CGOC is invested in companies operating in Canada, the U.S., Europe, Latin America, Jamaica and Israel, with an investment split across the private and public portfolios of approximately 40% and 60% respectively. CGOC’s top ten public investments as of November 15, 2019 (in alphabetical order) are: Bhang Inc (CSE: BHNG), C21 Investments (CSE: CXXI); Grassroots Cannabis, (not yet listed), Heritage Cannabis (CSE: CANN), Jushi Holdings Inc. (NEO: JUSH.B), LPF Investment Corp. (“Loudpack”, not yet listed) Next Green Wave (CSE: NGW), Planet 13 Holdings Inc. (CSE: PLTH), TerrAscend Corp. (CSE: TER), and VIVO Cannabis Inc. (TSX-V: VIVO).
Sean Conacher, Chief Executive Officer of CGOC commented, “CGOC realized a loss of 3% over last month compared to the North American Marijuana Index, which realized a 17% loss. Since CGOC’s IPO, our NAV has grown by 8% compared to the NAMMAR, as well as a number of other market indices which declined by an average of 66% in the same time period.
“The private portfolio continued to contribute positively to the overall portfolio performance, especially those outside of Canada. Our strategy of seeking out experienced and globally well positioned companies has allowed us to gain global exposure and invest relatively early on as illustrated by our investment in I.M.C Holdings Ltd. (now IM Cannabis Corp, CSE: IMCC) which listed on the Canadian Securities Exchange on November 5, 2019, to become the first Israeli medical cannabis operator to list its shares in Canada.”
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis5 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis5 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis4 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis3 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
SCHWAZZE3 days ago
Schwazze Announces First Quarter 2024 Financial Results